Himachal Pradesh Introduces Medical Cannabis Rules, Opening New Doors for Farmers, Research and Industry
New framework aims to encourage regulated cultivation, scientific innovation, local investment and value-added manufacturing in the state
Shimla: In a significant move towards developing a regulated medical cannabis industry, the Himachal Pradesh government has notified new rules for the cultivation, storage, research, processing and manufacturing of cannabis for medical and scientific purposes.
The Himachal Pradesh Narcotic Drugs and Psychotropic Substances (Amendment) Rules, 2026, issued by the Department of State Taxes and Excise on July 16, provide a detailed licensing and monitoring framework for individuals, farmer groups, institutions and businesses interested in participating in the sector. The rules will take effect from the date of their publication in the state’s official e-Gazette.
The notification creates a formal pathway for using the cannabis plant, excluding charas and ganja, for approved medical, scientific, research and industrial activities.
New opportunities for farmers and cooperatives
Under the new framework, individual farmers, groups of cultivators, cooperative societies and eligible institutions will be able to apply for licences to cultivate cannabis in areas notified by the government.
The proposed cultivation areas will be identified by the State Taxes and Excise Department and will be developed in compact, geographically connected zones to make administration and monitoring more effective.
For individual and collective cultivation, the proposed landholding should generally be at least three acres. However, government departments, universities and recognised research institutions will not be subject to this minimum-area requirement.
The rules could help farmers explore a new high-value crop while ensuring that cultivation is linked directly with licensed buyers and manufacturers.
Assured market through buyback arrangements
One of the most encouraging provisions is the requirement for cultivators to enter into a purchase agreement with a licensed manufacturer.
This buyback arrangement will help ensure that farmers have an identified buyer before beginning cultivation. It may reduce market uncertainty and create a more organised supply chain connecting cultivators with processing and manufacturing units.
Cultivators will also be able to work individually, through farmer groups or as members of registered cooperative societies.
Quality seeds and scientific testing
The new rules place a strong focus on quality and scientific standards.
Cannabis seeds will be supplied through authorised seed suppliers and supported by certificates of analysis. These certificates will contain details about seed quality and cannabinoid profiles, including THC and CBD concentrations.
Testing may be carried out by government laboratories, nationally accredited laboratories and other recognised scientific institutions.
This quality-control system is expected to support the production of standardised raw material suitable for medical research, pharmaceutical development and other authorised uses.
Scope for research and innovation
The notification creates separate licensing provisions for universities, laboratories, private research institutions and government departments interested in cannabis-related research and analytical testing.
Scientific research may include the study of cannabinoids such as CBD, THC, THCA and CBN, along with terpenes, flavonoids, plant varieties, indigenous seeds and potential medical applications.
The framework may encourage collaboration between universities, healthcare researchers, AYUSH institutions, biotechnology companies and pharmaceutical manufacturers.
It could also position Himachal Pradesh as an important centre for cannabis research, plant science and the development of evidence-based medical formulations.
Investment potential for Himachal Pradesh
The rules also establish a formal pathway for setting up cannabis-processing and manufacturing units in the state.
Manufacturing projects will require a minimum capital investment of ₹100 crore, indicating the government’s focus on attracting serious and professionally managed enterprises.
The annual licence fee for a manufacturing unit has been fixed at ₹2 crore. Licensed manufacturers undertaking their own cultivation will pay ₹10 lakh per bigha, while independent cultivation licences for medical and scientific purposes will carry an annual fee of ₹3 lakh per bigha.
Other licence categories include seed supply, warehousing, transportation, research and analytical testing.
The framework could encourage investment in processing facilities, laboratories, warehouses, cultivation infrastructure and value-added product development. It may also create employment opportunities in agriculture, research, logistics, quality testing and manufacturing.
Focus on organised and technology-enabled cultivation
Licensed cultivation will take place in controlled environments such as greenhouses and polyhouses.
Cultivation areas will be supported by GPS mapping, geo-tagging, CCTV surveillance and digital record-keeping. These measures are intended to improve transparency, maintain crop quality and build confidence among farmers, manufacturers, researchers and regulators.
The use of controlled cultivation environments can also help growers maintain consistency, improve plant health and produce raw material according to medical and scientific standards.
Structured supply chain from farms to manufacturers
The rules establish a clear system for the movement of cannabis produce from licensed farms to authorised warehouses and manufacturing units.
Transportation will take place through permits containing information about the vehicle, route, quantity, consignor and consignee. This system will help maintain traceability throughout the supply chain.
A transparent farm-to-factory process could make it easier for manufacturers to source verified raw material and for farmers to participate in an organised market.
Sustainability built into the framework
The notification also includes provisions for the responsible disposal of unused cannabis plant material.
Plant waste may be converted into compost, bio-fertiliser, biogas, biochar or other useful industrial inputs, subject to prescribed procedures. These provisions could encourage environmentally responsible practices and promote the productive use of agricultural residue.
Manufacturing units will also contribute a cess equal to 3% of their annual cannabis-business turnover. Of this, 2% will be directed towards the milk cess and 1% towards environmental initiatives.
Single-window review and district-level support
A State-Level Review Committee will be established to facilitate decision-making related to cultivation, warehousing, manufacturing, research and processing applications.
District-level committees will also monitor implementation, review compliance and coordinate between the Agriculture, Excise, Police, Revenue and AYUSH departments.
This institutional structure is expected to provide applicants with a more organised process and ensure coordinated implementation across different government departments.
A step towards a regulated medical cannabis ecosystem
The new rules represent an important step towards building a responsible medical and scientific cannabis ecosystem in Himachal Pradesh.
By bringing farmers, researchers, manufacturers and government departments under one regulated framework, the state has created opportunities for agricultural diversification, scientific research, investment and employment.
The success of the initiative will depend on the timely identification of cultivation zones, awareness among farmers, industry participation and effective cooperation between applicants and government authorities.
